Daniel A Shelly
Seminars
Wednesday 25th March 2026
Navigating Regulatory Pathways Across Next-Generation Treg Therapies
4:30 pm
- Establishing a regulatory foundation: Unraveling the regulatory journey from EMA clinical success to the FDA
- Utilizing targeting and conditioning to enhance therapeutic efficacy in T1D CAR-Treg therapies
- Shaping the future of targeted Treg therapies with multi-edited allogenic CAR-Tregs across a broad range of indications
Wednesday 25th March 2026
Industry Leader’s Fireside Chat: Evaluating the Global Treg Landscape to Explore the Future of Space
8:40 am
- Exploring the global Treg landscape to identify emerging opportunities and the direction of future Treg development
- Exploring the interest in Treg collaboration and investment amid industry changes and recent changes in the industry
- Discussing the broad landscape of Treg therapy economics considering cost, reimbursement and tariff impacts
